XBI241206C110000
- 0.09
- 0.000.00%
SPDR S&P Biotech ETF Newsroom
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Gilead Sciences Ticks Upward for the Eight Consecutive Session
Looking Into Natera's Recent Short Interest
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
December Starts With a Mixed Market | Live Stock
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Trending Stocks This Week as Holiday Season Begins With Thanksgiving Break
Stocks Ride to Best Month in a Year as 'Red Sweep' Unleashes 'Animal Spirits'
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Barclays's 'Bang-for-the-buck' Tail Hedging ETFs: HYG, XLF, IYR
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Wednesday Ends With Index Decline | Wall Street Today
Biotech ETF (XBI) Ended a Diagonal: Looking for Buying Dips
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Sarepta Therapeutics Analyst Ratings
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs